We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-7.35%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$680M
AUM Growth
+$240M
Cap. Flow
+$303M
Cap. Flow %
44.6%
Top 10 Hldgs %
20.02%
Holding
890
New
589
Increased
62
Reduced
40
Closed
122

Sector Composition

Rank Sector Weight
1 Financials 16.96%
2 Healthcare 15.53%
3 Consumer Discretionary 13.62%
4 Technology 13.52%
5 Industrials 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSG icon
526
Inseego
INSG
$111M
$135K 0.02%
+2,318
New +$151K
INVZ icon
527
Innoviz Technologies
INVZ
$93.2M
$135K 0.02%
+21,231
New +$122K
OMIC
528
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$135K 0.02%
+391
New +$152K
QFTA.WS
529
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$135K 0.02%
+265,500
New +$129K
MILE
530
DELISTED
Metromile, Inc. Common Stock
MILE
$135K 0.02%
+61,740
New +$176K
HYLN icon
531
Hyliion Holdings
HYLN
$646M
$134K 0.02%
+21,672
New +$155K
BIOR
532
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$134K 0.02%
+256
New +$184K
AMWL icon
533
American Well
AMWL
$181M
$133K 0.02%
+1,103
New +$168K
ANY icon
534
Sphere 3D
ANY
$18M
$133K 0.02%
+610
New +$236K
WIMI
535
WiMi Hologram Cloud
WIMI
$22.2M
$133K 0.02%
+4,360
New +$176K
ZEPP
536
Zepp Health
ZEPP
$64.8M
$133K 0.02%
+6,568
New +$197K
FRMM
537
Forum Markets
FRMM
$70.9M
$132K 0.02%
+9
New +$161K
KALV
538
DELISTED
KalVista Pharmaceuticals
KALV
$132K 0.02%
10,000
-2,754
-22% -$43.8K
KOPN icon
539
Kopin
KOPN
$663M
$132K 0.02%
+32,319
New +$164K
MARK
540
DELISTED
Remark Holdings, Inc.
MARK
$132K 0.02%
+13,268
New +$173K
GTH
541
DELISTED
Genetron Holdings Limited ADS
GTH
$132K 0.02%
+7,224
New +$239K
RAAS
542
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$132K 0.02%
+15,225
New +$172K
ABSI icon
543
Absci
ABSI
$1.29B
$131K 0.02%
+16,002
New +$182K
SRTA
544
Strata Critical Medical Inc
SRTA
$440M
$131K 0.02%
+14,805
New +$141K
BYSI icon
545
BeyondSpring
BYSI
$46.5M
$131K 0.02%
+28,854
New +$326K
VTEX icon
546
VTEX
VTEX
$745M
$131K 0.02%
+12,222
New +$191K
CAMP
547
DELISTED
CalAmp Corp.
CAMP
$131K 0.02%
+808
New +$179K
LTCH
548
DELISTED
Latch, Inc. Common Stock
LTCH
$131K 0.02%
+17,262
New +$153K
PLXP
549
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$131K 0.02%
+16,380
New +$192K
CIFR icon
550
Cipher Digital
CIFR
$9.27B
$130K 0.02%
+28,098
New +$205K

Similar funds

Alpine Global Management's Q4 2021 Portfolio in Review

As of Q4 2021, Alpine Global Management held 890 positions worth $680M, up 54% from $440M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Alpine Global Management deployed $303M of net new capital in Q4 2021, opening 589 new positions and adding to 62 existing holdings. Its largest new stake was iShares Biotechnology ETF: 82,290 shares worth $12.6M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was IHS Markit Ltd. Common Shares, an estimated $20.6M trimmed.

  • Alpine Global Management's largest Q4 2021 buy was iShares Biotechnology ETF: 82,290 shares worth $12.6M.
  • Alpine Global Management added most to Gores Guggenheim, Inc. Class A Common Stock in Q4 2021, an estimated $6.1M increase.
  • Alpine Global Management's biggest Q4 2021 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $20.6M.
  • Alpine Global Management fully exited Mirion Technologies in Q4 2021, selling an estimated $20.4M.
  • Alpine Global Management's ten largest holdings make up 20% of its $680M portfolio in Q4 2021.
  • Alpine Global Management opened 589 new positions and closed 122 in Q4 2021.
  • Alpine Global Management's portfolio value rose 54% quarter-over-quarter to $680M.

Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.